Introduction induce wild-type p53 (19). Recently, it was found that quercetin can down-regulate the estrogen receptor in an estrogenAndrogens play a critical role in regulating the growth, sensitive breast cancer cell line MCF-7 (20). differentiation and survival of epithelial cells in the normal
The LNCaP cell line is a well-established, androgen-responsprostate. Evidence shows that androgens are also involved in ive prostate cancer cell line obtained from a lymph node the development and progression of prostate cancer (1). The metastasis of a prostate cancer patient (21). LNCaP cells biological effects of androgens in the prostate are mediated express the AR and a number of androgen-inducible genes by the androgen receptor (AR), a ligand-activated transcription such as PSA, human glandular kallikrein (hK2), NKX3.1 and factor of the nuclear receptor superfamily (2). Endocrine ornithine decarboxylase (ODC), and their growth is stimulated therapy for prostate cancer is aimed at reducing the levels of by androgens. Recently, we have reported that some naturally circulating androgens or blocking agonist activation with occurring or synthetic compounds can modulate negatively the antagonists or both. However, endocrine therapy is only expression and function of AR (22) (23) (24) . In the present study, palliative. Prostate cancer relapses generally occur within we found that quercetin can inhibit the expression and function 1-2 years and become hormone refractory with a potentially of AR in LNCaP prostate cancer cells. fatal outcome (3).
Many molecular mechanisms have been postulated to be responsible for the development of recurrent hormone refractMaterials and methods ory tumors. Most of these mechanisms involve alterations in The membranes were washed three times for 10 min each with TBST. Antimouse HRP secondary antibody (Amersham, Piscataway, NJ) used at a 1 nM mibolerone (Mib) (NEN, Boston, MA). Mib is a synthetic androgen that is not metabolized in cell culture. Quercetin was purchased from Sigma 1:10 000 dilution was also incubated for 1 h at room temperature. The membranes were washed again and Renaissance chemiluminescence (NEN) (St Louis, MO) and dissolved in DMSO.
was used according to the manufacturer's instructions.
Western blot analysis
PSA and hK2 protein expression LNCaP or LAPC-4 cells were plated in 10 cm dishes at 9ϫ10 5 cells per dish in RPMI 1640 and 5% FCS. After 48 h the cells were treated with 1.0 nM LNCaP or LAPC-4 cells were seeded at 2ϫ10 4 cells per well in 24-well Mib and varying concentrations of quercetin. Cells were harvested at designated plates. After 2 days they were treated with varying amounts of quercetin with times, and the whole cell lysate was prepared according to Santa Cruz research or without 1 nM Mib. After a 5 day incubation, the spent media were harvest, applications. Nuclear extraction was prepared using the protocol described by and the levels of PSA and hK2 in spent media were quantified by an Andrews and Faller (25) . Protein levels were measured with a DC protein immunometric assay as described previously (26) . An MTS assay was assay (Bio-Rad, Hercules, CA). Protein samples (20 µg/sample) were loaded performed (Promega, Madison, WI) as per the manufacturer's instructions. into precast 4-12% NuPage gels (Novex, San Diego, CA), run with MOPS
The protein levels of PSA and hK2 were normalized by cell density buffer and transferred onto a nitrocellulose membrane (Bio-Rad) according to measurements with the MTS assay. the manufacturers' instructions. A Ponceau S stain was performed for total
Northern blots protein staining and visualized on a digital camera. The membranes were blocked overnight at 4°C in TBST (20 mM Tris-HCl pH 8.0, 137 mM NaCl LNCaP cells were treated with designated concentrations of quercetin with or without Mib. Cells were harvested 24 h later and RNA was isolated by the and 0.1% Tween 20) and 5% dry milk. The membranes were washed three times for 10 min each with TBST. Primary antibody for AR (1:2000 dilution) guanidine isothiocyanate method (27) . Total RNA (15 µg) was run in a denatured gel and transferred onto a nylon membrane according to the (Pharmingen, San Diego, CA), Sp1 (1:2000) (Santa Cruz Biotechonlgy, Inc., Santa Cruz, CA) or heat shock protein 70 (Hsp70) (1:2000) (StressGen GeneScreen protocol by New England Nuclear. cDNAs for PSA, NKX3.1, ODC and AR were used as probes labeled with [ 32 P]dCTP by random priming. Biotechnologies Corp., Canada) was incubated at room temperature for 1 h. The hybridization was performed according to Clontech's protocols with ExpressHyb hybridization solution. The films were autoradiographed at -70°C.
Transient transfections
LNCaP cells were plated in 60 mm dishes until they reached a confluency of 50-70%. Cells were co-transfected with CMV-β-galactosidase (β-gal) expression vector and pGL3 containing a 6 kb PSA promoter or 2 kb AR promoter using lipofectin (Life Technologies, Grand Island, NY), while the parental vector, pGL3, was used as a control. Twenty-four hours after the transfection, cells were treated with different concentrations of quercetin with or without Mib for an additional 24 h. Whole-cell extracts were prepared and a luciferase assay was performed according to manufacturer's instructions (Promega) for the PSA promoter/luciferase or AR promoter/luciferase transfection. β-gal activity was assayed for normalization purposes (28) . Each transfection was done three times and standard deviations were calculated.
Results

Quercetin inhibits the expression of AR protein
To determine whether AR protein levels are changed with quercetin treatment, western blots were performed. Figure 1a we prepared the nuclear extracts for western blot after quercetin quercetin was found as shown in Figure 1d . Quercetin inhibits PSA and hK2 secretion presence of androgen (Figure 3 ). This result demonstrates that In order to ascertain if quercetin can actually block androgen quercetin has a general inhibition effect on androgen-stimulated action, the androgen-dependent secretion of PSA and hK2 was gene expression. measured. Both PSA and hK2 are prostate-specific, androgenQuercetin inhibits the PSA gene at the transcription level regulated tumor markers (31, 32) . LNCaP or LAPC-4 cells were treated with different concentrations of quercetin with or It has been well documented that the PSA gene is mainly regulated by androgens at the transcription level via interaction without Mib for 5 days, spent media were harvested for assays of total PSA and hK2 proteins. The normalized data in Figure  of the AR with androgen-responsive elements in its promoter (37, 38) . To test whether the inhibitory effect of quercetin on 2 show that quercetin inhibits both PSA and hK2 protein levels in both LNCaP and LAPC-4 cells and in a dose-PSA expression occurs at the transcription level, we transfected a construct containing a 6 kb PSA promoter fragment in front dependent manner.
of a luciferase reporter gene into LNCaP cells with or without Quercetin inhibits the expression of other classes of androgenMib. As seen in Mib-treated cells, the PSA promoter gave a regulated genes strong androgenic induction of the luciferase activity, while In addition to PSA and hK2, NKX3.1 is also a prostatetransfection with the control vector, pGL3 basic, showed no specific, androgen-regulated gene coding for a homeodomain induction. Treatment with quercetin abolishes the androgenic transcription factor, which may play a role in the development induction of the 6 kb PSA promoter (P Ͻ 0.01) (Figure 4 ). and differentiation of the prostate (33, 34) . Ornithine decarbQuercetin inhibits the expression of the AR gene at the oxylase (ODC) catalyzes the first and rate-limiting step on transcription level polyamine synthesis (35) and is regulated by androgen in prostate cells (36) . Northern blot analysis showed quercetin
To shed further light on the mechanism by which quercetin inhibits the expression of AR, northern blot analysis was done. greatly reduced PSA, NKX3.1 and ODC mRNA levels in the As shown in Figure 5a , AR mRNA was down-regulated by hK2, NKX3.1 and ODC, which play roles in development and progression of prostate cancer. Quercetin has the potential to quercetin treatment. To further ascertain that quercetin can affect AR at the transcription level, gene transfer assays were become a chemopreventive and/or chemotherapeutic agent for prostate cancer. performed with a 2 kb AR promoter. Figure 5b shows that the 2 kb AR promoter activity was decreased by quercetin (P Ͻ 0.01) regardless of the presence or absence of androgens. Acknowledgement This experiment strongly demonstrates that quercetin blocks the expression of the AR gene at transcription level.
This work is partly supported by the NIH grants DK 41995 and CA 70982. prostate cancer compared to benign tissue (46) . Together, our 19 . Plaumann,B., Fritsche,M., Rimpler,H., Brandner,G. and Hess,R.D. (1996) study strongly suggests that quercetin has an inhibitory effect down-regulate the androgen-inducible genes including PSA,
Discussion References
